Page 67 - Merck Sharp News Today

Obesity in adolescence is linked to an increased risk for type 1 diabetes onset in adulthood, new research suggests.

CHICAGO — The addition of panitumumab vs. bevacizumab to standard doublet chemotherapy significantly extended survival among patients with RAS wild-type and left-sided metastatic colorectal cancer, according to study results.The panitumumab (Vectibix, Amgen) regimen conferred median OS of more than 3 years —— the longest survival ever reported in a first-line, prospective phase

- 92% (n=22/24) of Evaluable Patients Achieved Complete Response (CR) at the Initial 3-Month Timepoint from the Phase 2 Clinical Trial of CG0070, an Oncolytic Immunotherapy, in Combination with KEYTRUDA® (pembrolizumab) for NMIBC Unresponsive to BCG -- Promising Preliminary Efficacy and Safety Data from the Phase 1b...

90% of patients achieve tumor size reductions40% of patients achieve partial response, i.e. tumor size reductions of more than 50%BERLIN--(BUSINESS WIRE)--Regulatory News:NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the t...

Avacopan and mepolizumab feature in new European recommendations for managing antineutrophil cytoplasmic antibody-associated vasculitis.

Recommendations for the management of patients with axial spondyloarthritis (axSpA) emphasize both pharmacologic and nonpharmacologic therapies.

Data Show INT230-6 is Well Tolerated and Elicits Both Direct Tumor Killing and Immune Activating Effects in a Variety of Solid Tumors Patients Receiving a Dose...

Following revelations that the University of Sydney produced an eye-watering $1.04 billion surplus last year, student-staff ratio has crashed to the worst level…

/PRNewswire/ -- DelveInsights Checkpoint Inhibitor Refractory Cancer Market Insights report covers a detailed comprehension of Checkpoint Inhibitor Refractory...

Foodborne Trematodiases Disease Market Industry Future Growth, Latest Technology, New Demands, Business Challenges, Opportunities and Industry Trends